Cargando…
Should COVID-19 be considered cardiovascular disease risk equivalent?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884400/ https://www.ncbi.nlm.nih.gov/pubmed/36724830 http://dx.doi.org/10.1016/j.ijcard.2023.01.076 |
_version_ | 1784879710274060288 |
---|---|
author | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
author_facet | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
author_sort | Kow, Chia Siang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9884400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98844002023-01-30 Should COVID-19 be considered cardiovascular disease risk equivalent? Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Int J Cardiol Letter to the Editor Elsevier B.V. 2023-04-15 2023-01-29 /pmc/articles/PMC9884400/ /pubmed/36724830 http://dx.doi.org/10.1016/j.ijcard.2023.01.076 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Should COVID-19 be considered cardiovascular disease risk equivalent? |
title | Should COVID-19 be considered cardiovascular disease risk equivalent? |
title_full | Should COVID-19 be considered cardiovascular disease risk equivalent? |
title_fullStr | Should COVID-19 be considered cardiovascular disease risk equivalent? |
title_full_unstemmed | Should COVID-19 be considered cardiovascular disease risk equivalent? |
title_short | Should COVID-19 be considered cardiovascular disease risk equivalent? |
title_sort | should covid-19 be considered cardiovascular disease risk equivalent? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884400/ https://www.ncbi.nlm.nih.gov/pubmed/36724830 http://dx.doi.org/10.1016/j.ijcard.2023.01.076 |
work_keys_str_mv | AT kowchiasiang shouldcovid19beconsideredcardiovasculardiseaseriskequivalent AT ramachandramdineshsangarran shouldcovid19beconsideredcardiovasculardiseaseriskequivalent AT hasansyedshahzad shouldcovid19beconsideredcardiovasculardiseaseriskequivalent |